Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis

Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis

Ann Margaret Dyer, Alan Smith PharmaSci Consulting Limited, Nottingham, UK Abstract: The aim of the present work is to extensively evaluate the pharmaceutical attributes of currently available riluzole presentations. The article describes the limitations and risks associated with the administratio...

Full description

Bibliographic Details
Main Authors: Dyer AM, Smith A
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:Drug Design, Development and Therapy
Subjects:
Amyotrophic lateral sclerosis
riluzole
dysphagia
patient compliance
oral liquid
Online Access:https://www.dovepress.com/riluzole-5-mgml-oral-suspension-for-optimized-drug-delivery-in-amyotro-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/riluzole-5-mgml-oral-suspension-for-optimized-drug-delivery-in-amyotro-peer-reviewed-article-DDDT

Similar Items